Earnings To Watch: Cadre (CDRE) Reports Q4 Results Tomorrow

StockStory
03-10
Earnings To Watch: Cadre (CDRE) Reports Q4 Results Tomorrow

Aerospace and defense company Cadre (NYSE:CDRE) will be reporting results tomorrow after market hours. Here’s what to look for.

Cadre missed analysts’ revenue expectations by 15.3% last quarter, reporting revenues of $109.4 million, down 12.6% year on year. It was a softer quarter for the company, with a miss of analysts’ Products revenue estimates and a significant miss of analysts’ adjusted operating income estimates.

Is Cadre a buy or sell going into earnings? Read our full analysis here, it’s free.

This quarter, analysts are expecting Cadre’s revenue to grow 37.9% year on year to $171.7 million, improving from its flat revenue in the same quarter last year. Adjusted earnings are expected to come in at $0.51 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Cadre has missed Wall Street’s revenue estimates twice over the last two years.

Looking at Cadre’s peers in the aerospace and defense segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Byrna delivered year-on-year revenue growth of 78.9%, meeting analysts’ expectations, and Axon reported revenues up 33.6%, topping estimates by 1.5%. Byrna traded up 24.6% following the results while Axon was also up 14.7%.

Read our full analysis of Byrna’s results here and Axon’s results here.

Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. We prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10